SCHEMBL4934032

SCHEMBL4934032

COc1ccccc1C(C)(CN)N(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
TAAR1 Q96RJ0 2/20 0.41
AOC3 Q16853 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
ADRA2B P18089 1/20 0.38
PTGS1 P23219 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
KDM4E B2RXH2 1/20 0.37
IDO1 P14902 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26633904 0.78 TAAR1 (0.47) ALDH1A1TAAR1CA12CA1CA2
Hydrochloric Acid SCHEMBL28044187 0.77 TAAR1 (0.45) ALDH1A1TAAR1CA12CA1CA2
SCHEMBL1132364 0.76 TAAR1 (0.44) ALDH1A1TAAR1AOC3CA12CA1
SCHEMBL15473812 0.76 CA1 (0.48) ALDH1A1AOC3CA12CA1CA2
SCHEMBL21632350 0.73 GAA (0.44) ALDH1A1TAAR1CA12CA1CA2
SCHEMBL23886282 0.73 CA1 (0.44) ALDH1A1TAAR1CA12CA1CA2
SCHEMBL4934040 0.72 AOC3 (0.40) ALDH1A1TAAR1AOC3CA12CA1
Hydrochloric Acid SCHEMBL9275355 0.71 CA1 (0.43) ALDH1A1TAAR1CA12CA1CA2
Hydrochloric Acid SCHEMBL29681943 0.71 CA1 (0.43) ALDH1A1TAAR1CA12CA1CA2
SCHEMBL4631777 0.71 CA1 (0.52) ALDH1A1TAAR1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080076774-A1 Kinase Modulators and Methods of Use EXELIXIS, INC. (US) 2008-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076774-A1 Kinase Modulators and Methods of Use AKT3, RPS6KA3, CDK3 ALDH1A1 4305/4885TAAR1 4523/4885AOC3 4430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.